CNC vs SRPT · P/E 8.4, rev $163.07B vs rev $1.90B
Centene Corp (CNC) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CNC and SRPT stock pages for the full models.
Not investment advice.